Darren Woodside

Cell adhesion research could lead to a new pain alternative for patients with inflammatory conditions 

Today more than 30 million patients suffer from painful inflammatory conditions. Prescription opioid pain relievers are commonly prescribed for these...

THI discovery targets inflammatory disease for patients suffering from IBD

Grant from the NIH NIDDK to Advance Collaboration to Develop Treatments for Inflammatory Disease HOUSTON, TX, November 10, 2020 –...

Discovery in the molecular cardiology research labs could improve immuno-oncology drugs, covid, and influenza vaccines

Texas Heart Institute scientists illuminated a molecular pathway that could one day strengthen the immune response to immunotherapies. The first-in-human...

Biomedical Engineer to Expand THI’s Innovation Partnerships

HOUSTON, TX (October 9, 2020) – The Texas Heart Institute is proud to announce the appointment of Dr. Allison Post...

Technology Co-Invented by THI Scientists In the News

Technology co-invented by scientists at the Texas Heart Institute and 7 Hills Pharma received broad patent protection from the U.S....

Texas Heart Institute & 7 Hills Pharma awarded a $1.9 million grant from National Heart Lung Blood Institute to improve stem cell transplantation

HOUSTON, TX (June 11, 2020) —The Texas Heart Institute and 7 Hills Pharma (7 Hills) received a $1.9 million, Phase...

Harnessing hydrogels to fine-tune the body’s inflammatory response

Rice University partnered with the Texas Heart Institute (THI) to define the body’s response to their injectable hydrogels that are...

Texas Heart Institute’s molecular discovery at the heart of a new vaccine development program

A promising molecular technology co-invented by scientists at the Texas Heart Institute and 7 Hills could soon enhance the effectiveness...

Texas Heart Institute Discovery to Enhance the Immune System Moves Closer to Clinical Testing

A promising technology invented at the Texas Heart Institute is one step closer to being tested in a clinical study...